Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 70710-1987

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70710-1987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1ead94f4 7af5 4d75 81ac 85a93490ecb2 01)

Chemical structure of the active ingredient Sitagliptin, showing the molecular arrangement including trifluoromethyl and trifluorophenyl groups as part of the compound.*

FDA Label Image

Structure (1ead94f4 7af5 4d75 81ac 85a93490ecb2 02)

Chemical structure of Sitagliptin and Metformin Hydrochloride, showing the molecular arrangement including amine, methyl groups, and hydrochloride component.*

FDA Label Image

Graph (1ead94f4 7af5 4d75 81ac 85a93490ecb2 03)

A line graph illustrating the least squares mean change from baseline over 24 weeks for different oral treatment regimens including placebo, metformin 1000 mg b.i.d., sitagliptin 100 mg q.d., sitagliptin 50 mg b.i.d., metformin 500 mg b.i.d., and their combinations. The y-axis shows mean change from baseline, and the x-axis represents weeks from 0 to 24.*

FDA Label Image

Graph (1ead94f4 7af5 4d75 81ac 85a93490ecb2 04)

A line graph comparing the least squares mean change from baseline over 52 weeks for Sitagliptin 100 mg and Glipizide. The x-axis represents weeks (0 to 52), and the y-axis shows LS mean change values from 0.0 to -1.5. Both lines show a sharp decrease initially, leveling off between weeks 12 and 30, followed by a gradual increase towards week 52.*

FDA Label Image

Label (1ead94f4 7af5 4d75 81ac 85a93490ecb2 05)

Label for Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg, film coated oral tablets. The label indicates 60 tablets per bottle, prescription use only, and includes storage and usage instructions. It is distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Zydus Lifesciences Ltd. The label features NDC 70710-1986-6 and patient medication guide information.*

FDA Label Image

Label (1ead94f4 7af5 4d75 81ac 85a93490ecb2 06)

Label for Sitagliptin and Metformin Hydrochloride Tablets, film coated, 50 mg/1000 mg strength, manufactured by Zydus Pharmaceuticals (USA) Inc. The label includes dosage information, storage instructions, and a barcode. The package contains 60 tablets and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.